ADCYAP1 and Headache: These findings suggest that PACAP38-induced headache in healthy volunteers can be attenuated by sumatriptan independently from vasoconstriction, with time-dependent preventative effects probably inhibiting central sensitization by blocking peripheral signal transmission from the meningeal nociceptors [35].